The impact of a comprehensive pharmaceutical care intervention in addition to cardiac rehabilitation program on outcomes of post-acute coronary syndrome patients: A pilot study

Casper, Eman; Wakeel, L. Mohmed El; Saleh, Mohamed Essam; El‐Hamamsy, Manal

doi:10.1016/j.pec.2022.06.004

Cited by 2 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Experience with utilizing the pharmacists' potential in promoting self-care as a component of interventions in other settings can be used to inform similar work in the community practice setting. Positive data includes pharmacists providing education on exercise training, healthy diet, and behaviour modification in cardiac rehabilitation units 31 in addition to enhancing the understanding and adherence of patients with hemodialysis to the treatment plan and encouraging self-management strategies in hospitals, 32 and engaging in interprofessional work to serve with self-isolated COVID-19 patients in rural areas remotely using phone calls and social media applications to encourage healthy diets and smoking cessation. 33 Further, pharmacists serving paediatric patients with Iron-overloaded β-thalassemia major within a children's hospital created simplified educational materials in the form of a story with various episodes for patient education.…”

Section: Pharmacy Practice Law and Staffmentioning

confidence: 99%

Egyptian community pharmacies and self-care: Context, challenges and opportunities

Youssef,

Amin

2023

Exploratory Research in Clinical and Social Pharmacy

View full text Add to dashboard Cite

Section: Pharmacy Practice Law and Staffmentioning

confidence: 99%

Egyptian community pharmacies and self-care: Context, challenges and opportunities

Youssef,

Amin

2023

Exploratory Research in Clinical and Social Pharmacy

View full text Add to dashboard Cite

“…Several studies have shown that clinical pharmacist interventions can significantly improve patient knowledge of CHD and secondary prevention drugs, leading to improved medication adherence (Ho et al, 2014;Ahmed Casper et al, 2022;Hong et al, 2022;Weeda et al, 2023). Pharmacist interventions can promptly detect and resolve adverse drug reactions (ADRs) and better control patient risk factors and clinical parameters (Phatak et al, 2016;Casper et al, 2019).…”

Section: Introductionmentioning

confidence: 99%

Impact of continuous pharmaceutical care led by clinical pharmacists during transitions of care on medication adherence and clinical outcomes for patients with coronary heart disease: a prospective cohort study

Gao,

Han,

Jia

et al. 2023

Front. Pharmacol.

View full text Add to dashboard Cite

Objectives: The study aimed to explore the impact of a continuous pharmaceutical care (CPC) program during care transitions on medication adherence and clinical outcomes for patients with coronary heart disease (CHD).Methods: A prospective cohort study was conducted from April 2020 to February 2021. Patients diagnosed with CHD were selected and divided into intervention (CPC) and usual care (UC) groups by nurses at equal intervals based on admission time. The intervention group received CPC services provided by clinical pharmacists (including medication reconciliation, disease education, medication guidance, lifestyle counseling, and follow-up services) and usual care. The UC group received only routine medical care. The study compared medication adherence, clinical indicators (low-density lipoprotein cholesterol [LDL-C], blood pressure [BP], glycated hemoglobin [HbA1c] control rates), the incidence of adverse drug reactions (ADRs), and readmission rates (overall, major adverse cardiovascular events [MACEs]-related, and CHD risk factors-related) at admission and 1, 3, and 6 months after discharge between the two groups.Results: A total of 228 patients with CHD completed the study, including 113 patients in the CPC group and 115 patients in the UC group. There were no significant differences (p > 0.05) in both groups in demographic and clinical characteristics at baseline. A total of 101 drug-related problems were identified in the CPC group (an average of 0.89 per person). The CPC group showed significantly higher medication adherence at 1, 3, and 6 months after discharge than the UC group (p < 0.05). At 3 and 6 months after discharge, the intervention group had significantly higher control rates of LDL-C (61.11% vs. 44.64% at 3 months, 78.18% vs. 51.43% at 6 months), and BP (91.15% vs. 77.39% at 3 months, 88.50% vs. 77.19% at 6 months). The CPC group had higher HbA1c control rates (53.85% vs. 34.21% at 3 months, 54.05% vs. 38.46% at 6 months) than the UC group. However, the differences were not statistically significant. The incidence of ADRs 6 months after discharge was significantly lower in the CPC group than in the UC group (5.13% vs. 12.17%, p < 0.05). The CPC group had a lower overall readmission rate (13.27% vs. 20.00%), MACE-related readmission rate (5.31% vs. 12.17%), and readmission rate related to CHD risk factors (0.88% vs. 2.61%) 6 months after discharge compared to the UC group. However, these differences were not statistically significant (p > 0.05).Conclusion: CPC led by clinical pharmacists during care transitions effectively improved medication adherence, safety, and risk factor control in patients with CHD.

show abstract

The impact of a comprehensive pharmaceutical care intervention in addition to cardiac rehabilitation program on outcomes of post-acute coronary syndrome patients: A pilot study

Cited by 2 publications

References 18 publications

Egyptian community pharmacies and self-care: Context, challenges and opportunities

Egyptian community pharmacies and self-care: Context, challenges and opportunities

Impact of continuous pharmaceutical care led by clinical pharmacists during transitions of care on medication adherence and clinical outcomes for patients with coronary heart disease: a prospective cohort study

Contact Info

Product

Resources

About